CLINICAL_TRIALS
trial_result
· 2014-10-29
Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout [Phase 3]
Summary
This clinical trial update reports that a Phase 3 study evaluating the safety and efficacy of oral febuxostat in gout has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Taiwan, Inc. | Conditions: Gout | Phase 3 | Status: COMPLETED